E-resources
-
Fauci, Anthony S.; Marovich, Mary A.; Dieffenbach, Carl W.; Hunter, Eric; Buchbinder, Susan P.
Science, 04/2014, Volume: 344, Issue: 6179Journal Article
Future HIV vaccine research should consider the balance between responses that favor protection and those that lead to susceptibility to infection. The development of a safe and effective HIV vaccine is perhaps the most important and challenging goal remaining in HIV-AIDS research. Recent progress using a poxvirus vector prime and envelope protein boost strategy demonstrated a modest but statistically significant level of efficacy and established the concept that a vaccine could prevent HIV infection ( 1 ), and approaches to boost durability and efficacy are currently in the planning stages ( 2 ). But the results of two vaccine concepts based on recombinant adenovirus serotype-5 (rAd5) ( 3 – 5 ) pointed to a potential major problem—that such vaccines might increase susceptibility to HIV infection. This also raised the question of whether the problem extends to some or all of the other recombinant adenovirus vectors currently in development or to other vector-based vaccines.
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.